John R. Bristol

E5531, a Pure Endotoxin Antagonist of High Potency

William J. Christ, Osamu Asano, Andrea L. C. Robidoux et al. · Science · 1995 · 321 citations

Pharmacotherapy, Viable Escherichia Coli, Drug Resistance +16

Inhibition of Endotoxin Response by E5564, a Novel Toll-Like Receptor 4-Directed Endotoxin Antagonist

Maureen Mullarkey, Jeffrey Rose, John R. Bristol et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 290 citations

E5531, a synthetic non‐toxic lipid A derivative blocks the immunobiological activities of lipopolysaccharide

Tsutomu Kawata, John R. Bristol, Daniel P. Rossignol et al. · British Journal of Pharmacology · 1999 · 63 citations · Full text

Kinetic Mechanism of the p38-α MAP Kinase:  Phosphoryl Transfer to Synthetic Peptides

Guanjing Chen, Margaret Porter, John R. Bristol et al. · Biochemistry · 2000 · 54 citations

Molecular Biology, Synthetic Peptides, Peptide Science +19

Agonistic and antagonistic activities of bacterially derived Rhodobacter sphaeroides lipid A: comparison with activities of synthetic material of the proposed structure and analogs

Jeffrey Rose, William J. Christ, John R. Bristol et al. · Infection and Immunity · 1995 · 52 citations · Full text

Bioorganic Chemistry, Engineering, Nitric Oxide +16